George Capuano - Concepedia

Author

George Capuano

Janssen (United States)

Also Known As

G Capuano, G. Capuano, GEORGE CAPUANO, George A. Capuano, George Capuano

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)University Medical Center Groningen The University of Sydney Royal North Shore Hospital University of Groningen

About

George Capuano is an author at Janssen (United States) specializing in medicine, factor analysis, and statistics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	78
2	Public Health	1	1	54
3	Biostatistics	1	1	25
4	Diabetes	1	1	24
5	Pharmacology	1	1	24

George Capuano

Publications

Citations

H-Index

Page 1

	Year	Citations
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Vlado Perkovic, Meg Jardine, Bruce Neal, New England Journal of Medicine	2019	5.7K
Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes Julio Rosenstock, Naresh Aggarwal, David Polidori, Diabetes Care	2012	415
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study Marvin S. Swartz, Diana O. Perkins, T. Scott Stroup, American Journal of Psychiatry	2007	283
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint, Circulation	2019	280
Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Diabetes Care	2014	235
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE Study T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, American Journal of Psychiatry	2007	157
Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes Julio Rosenstock, Leonard Chuck, Manuel González-Ortı́z, Diabetes Care	2016	144
Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies Paul Nyirjesy, Jack D. Sobel, Albert Fung, Current Medical Research and Opinion	2014	135
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2 George L. Bakris, Megumi Oshima, Kenneth W. Mahaffey, Clinical Journal of the American Society of Nephrology	2020	131
Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes Gregory Fulcher, David R. Matthews, Vlado Perkovic, Diabetes Obesity and Metabolism	2015	91

Page 1